Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women
Clinical trial NCT07492706 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07492706
- Sponsor
- MAXVAX Biotechnology Limited Liability Company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2026-04-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.